Olga V Beznos
Overview
Explore the profile of Olga V Beznos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eremeev R, Efremov A, Efremov A, Zakharova D, Beznos O, Sokolova E, et al.
ChemMedChem
. 2025 Feb;
:e202400977.
PMID: 39988564
Oxindole-based natural indoles analogues retain the rigidity and size of the original indole ring system whilst introducing more 3-dimensionality and potential increased water solubility. We report the first preparation of...
2.
Eremeev R, Beznos O, Efremov A, Chesnokova N, Lozinskaya N
Bioorg Med Chem Lett
. 2023 May;
90:129334.
PMID: 37207847
Compounds with a 2-oxindole scaffold play an important role in organic synthesis and especially in the synthesis of bioactive organic compounds, therefore, the development of new methods for modifying this...
3.
Efremov A, Beznos O, Eremeev R, Chesnokova N, Milaeva E, Shevtsova E, et al.
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982181
Glaucoma is a widespread neurodegenerative disease for which increased intraocular pressure (IOP) is a primary modifiable risk factor. Recently, we have observed that compounds with oxindole scaffolds are involved in...
4.
Popova E, Tikhomirova V, Beznos O, Chesnokova N, Grigoriev Y, Klyachko N, et al.
Nanomedicine
. 2021 Nov;
40:102493.
PMID: 34775060
Formulations on the base of an inhibitor of angiotensin-converting enzyme, enalaprilat, were prepared by the inclusion of the drug into calcium phosphate (CaP)-particles in situ, followed by the covering of...
5.
Vaneev A, Kost O, Eremeev N, Beznos O, Alova A, Gorelkin P, et al.
Biomedicines
. 2021 Apr;
9(4).
PMID: 33917028
Inflammatory eye diseases remain the most common clinical problem in ophthalmology. The secondary processes associated with inflammation, such as overproduction of reactive oxygen species (ROS) and exhaustion of the endogenous...
6.
Zaryanova E, Lozinskaya N, Beznos O, Volkova M, Chesnokova N, Zefirov N
Bioorg Med Chem Lett
. 2017 Jul;
27(16):3787-3793.
PMID: 28687205
The study represents the new findings at the crossroads of chemistry and medicine, particularly between medicinal and organic chemistry and ophthalmology. In this work we describe how the chemical reactivity...
7.
Kost O, Beznos O, Davydova N, Manickam D, Nikolskaya I, Guller A, et al.
Oxid Med Cell Longev
. 2015 Dec;
2015:5194239.
PMID: 26697135
Use of antioxidants to mitigate oxidative stress during ocular inflammatory diseases has shown therapeutic potential. This work examines a nanoscale therapeutic modality for the eye on the base of antioxidant...